Centaur Pharmaceuticals Pvt. Ltd. (2018). Glimepiride+Metformin+Voglibose [Product Monograph]. Punjab, India.
Dabhi, A. S., Bhatt, N. R., & Shah, M. J. (2013). Voglibose: An Alpha Glucosidase Inhibitor. Journal of Clinical and Diagnostic Research, 7(12), 3023-3027.
MedlinePlus. (n.d.). Glimepiride: MedlinePlus Drug Information. Retrieved from https://medlineplus.gov/druginfo/meds/a696016.html
MedlinePlus. (n.d.). Metformin: MedlinePlus Drug Information. Retrieved from https://medlineplus.gov/druginfo/meds/a696005.html
PMC. (n.d.). Voglibose: An Alpha Glucosidase Inhibitor. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919386/
Das, A. K., Wangnoo, S. K., Chawla, R., Shaikh, A., Bantwal, G., Kalra, P., ... & Sarda, P. (2022). Expert consensus on triple combination of glimepiride, metformin, and voglibose usage in patients with type 2 diabetes mellitus in Indian settings. Journal of Diabetology, 13(2), 145-153.
Jindal, A., Jindal, M., Kaur, M., Kumar, R., & Brar, R. S. (2014). Efficacy and safety of voglibose as an add-on triple drug in patients of type two diabetes mellitus uncontrolled with glimepiride and metformin in punjabi population. Indian J Basic Appl Med Res, 3(3), 111-6.
BANTWAL, G., AYYAR, V., KOVIL, R., CHAWLA, M., SHAH, T., KUMAR, S., ... & REVANKAR, S. (2021). Assessment of Clinical Experience of Triple Drug Fixed-dose Combination of Glimepiride, Metformin and Voglibose in the Management of Type 2 Diabetes Mellitus: A Retrospective Study. Journal of Clinical & Diagnostic Research, 15(9).